US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vital Therapies

0.8300

0.0000

Volume:- -

Turnover:- -

Market Cap:879.17K

PE:-0.97

High:0.8300

Open:0.8300

Low:0.8300

Close:0.8300

52wk High:9.75

52wk Low:0.1510

Shares:1.06M

Float Shares:978.17K

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8566

EPS(LYR):-0.9789

ROE:--

ROA:--

PB:0.10

PE(LYR):-0.85

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Vital Therapies

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.vitaltherapies.com/

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure in the United States. Its ELAD system is an extracorporeal human allogeneic cellular liver that is in Phase III clinical trials to allow the patients own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VTL/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTL\",,,,,undefined,":{"symbol":"VTL","market":"US","secType":"STK","nameCN":"Vital Therapies","latestPrice":0.83,"timestamp":1555099199999,"preClose":0.83,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":978173,"shares":1059242,"eps":-0.85656,"marketStatus":"Market Closed","change":0,"latestTime":"04-12 15:59:59 EDT","open":0.83,"high":0.83,"low":0.83,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.85656,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"symbolChange":{"newSymbol":"IMUX","executeDate":"2019-04-15"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.83,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTL\",,,,,undefined,":{"symbol":"VTL","floatShares":978173,"roa":"--","roe":"--","lyrEps":-0.978894,"shares":1059242,"dividePrice":0,"high":0.83,"amplitude":0,"preClose":0.83,"low":0.83,"week52Low":0.151,"pbRate":"0.10","week52High":9.75,"institutionHeld":0,"latestPrice":0.83,"eps":-0.85656,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.85656,"open":0.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-04-15","symbol":"VTL","type":"split","dateTimestamp":1555300800000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2019-03-04","symbol":"VTL","fiscalQuarterEnding":"2018/12","expectedEps":0.49,"name":null,"time":"","type":"earning","dateTimestamp":1551675600000,"reportTimeType":"","actualEps":-0.06},{"market":"US","date":"2018-11-07","symbol":"VTL","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1541566800000,"reportTimeType":"","actualEps":-0.28},{"market":"US","date":"2018-08-07","symbol":"VTL","fiscalQuarterEnding":"2018/06","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1533614400000,"reportTimeType":"post","actualEps":-0.3},{"market":"US","date":"2018-05-08","symbol":"VTL","fiscalQuarterEnding":"2018/03","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1525752000000,"reportTimeType":"post","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.vitaltherapies.com/","stockEarnings":[{"period":"1week","weight":-0.975},{"period":"1month","weight":-0.975},{"period":"3month","weight":-0.975},{"period":"6month","weight":-0.975},{"period":"1year","weight":-0.975},{"period":"ytd","weight":-0.975}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure in the United States. Its ELAD system is an extracorporeal human allogeneic cellular liver that is in Phase III clinical trials to allow the patients own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.","exchange":"NASDAQ","name":"Vital Therapies","nameEN":"Vital Therapies"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VTL\",market:\"US\",,,undefined,":null}}